Publication Cover
New Genetics and Society
Critical Studies of Contemporary Biosciences
Volume 36, 2017 - Issue 4
817
Views
7
CrossRef citations to date
0
Altmetric
Articles

The price of an egg: oocyte donor compensation in the US fertility industry

Pages 354-374 | Received 19 Apr 2017, Accepted 20 Sep 2017, Published online: 20 Oct 2017

References

  • Alberta, H., R. Berry, and A. Levine. 2013. “Compliance with Donor Age Recommendations in Oocyte Donor Recruitment Advertisements in the USA.” Reproductive BioMedicine Online 26: 400–405. doi: 10.1016/j.rbmo.2012.11.011
  • Aldrich, H., and M. Ruef. 2006. Organizations Evolving. 2nd ed. London: Sage.
  • Almeling, R. 2011. Sex Cells: The Medical Market for Eggs and Sperm. Berkeley: University of California Press.
  • ASRM (American Society for Reproduction Medicine). 2006. Third Party Reproduction (Sperm, Egg and Embryo Donation and Surrogacy): A Guide for Patients. American Society for Reproductive Medicine.
  • Barman, E. 2002. “Asserting Difference: The Strategic Response of Non-profit Organizations to Competition.” Social Forces 80 (4): 1191–1222. doi: 10.1353/sof.2002.0020
  • Birch, Kean. 2017. “Rethinking Value in the Bio-Economy: Finance, Assetization, and the Management of Value.” Science Technology and Human Values 42 (3): 460–490.
  • Braverman, A. M. 2010. “How the Internet Is Reshaping Assisted Reproduction: From Donor Offspring Registries to Direct-to-Consumer Genetic Testing.” Minnesota Journal of Law, Science & Technology 11 (2): 477–496.
  • CDC (Center for Disease Control). n.d. “ Fertility Clinic Success Rate and Certification Act.” Center for Disease Control.
  • Clarke, A. 1990. “Controversy and the Development of Reproductive Sciences.” Social Problems 37 (1): 18–37. doi: 10.2307/800792
  • Conrad, P., and V. Leiter. 2004. “Medicalization, Markets, and Consumers.” Journal of Health and Social Behavior 45: 158–176.
  • Covington, S. N., and W. E. Gibbons. 2007. “What Is Happening to the Price of Eggs?” Fertility & Sterility 87 (5): 1001–1004. doi: 10.1016/j.fertnstert.2006.12.037
  • Crockin, S. L., and H. W. Jones. 2010. “Maternity and Egg Donation.” In Legal Conceptions: The Evolving Law and Policy of Assisted Reproductive Technologies, 188–208. Baltimore: The Johns Hopkins University Press.
  • DiMaggio, P. J., and W. W. Powell. 1983. “The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational Fields.” American Sociological Review 48: 147–160. doi: 10.2307/2095101
  • Duka, W. E., and A. H. DeCherney. 1994. From the Beginning: A History of the American Fertility Society. Birmingham, AL: The American Fertility Society.
  • Ersts, P. J. n.d. Geographic Distance Matrix Generator (version 1.2.3). American Museum of Natural History, Center for Biodiversity and Conservation.
  • Gershman, J. 2016. “ Fertility Industry Group Settles Lawsuit over Egg Donor Price Caps.” The Wall Street Journal, February 3.
  • Gunningham, N., and J. Rees. 1997. “Industry Self-regulation: An Institutional Perspective.” Law & Policy 19 (4): 363–414. doi: 10.1111/1467-9930.t01-1-00033
  • Gurmankin, A. 2001. “Risk Information Provided to Prospective Oocyte Donors in a Preliminary Phone Call.” American Journal of Bioethics 1 (4): 3–13. doi: 10.1162/152651601317139207
  • Hamilton, B. H., and B. McManus. 2005a. “Infertility Treatment Markets: The Effects of Competition and Policy.” Unpublished Working Paper.
  • Hamilton, B. H., and B. McManus. 2005b. “Technology Diffusion and Market Structure: Evidence from Infertility Treatment Markets.” Unpublished Working Paper.
  • Henne, M. B., and M. K. Bundorf. 2010. “The Effects of Competition on Assisted Reproductive Technology Outcomes.” Fertility & Sterility 93 (6): 1820–1830. doi: 10.1016/j.fertnstert.2008.02.159
  • Holster, K. 2008. “Making Connections: Egg Donation, the Internet, and the New Reproductive Technology Marketplace.” Advances in Medical Sociology 10: 53–73. doi: 10.1016/S1057-6290(08)10004-3
  • Holwell, E., J. Keehn, C. Leu, M. Sauer, and R. Klitzman. 2014. “Egg Donation Brokers: An Analysis of Agency Versus In Vitro Fertilization Clinic Websites.” Journal of Reproductive Medicine 59: 534–541.
  • Johnson, K. M. 2011. “Fertility Clinic, Egg Donation Agency, and Sperm Bank Policies.” Fertility & Sterility 96 (4): 877–879. doi: 10.1016/j.fertnstert.2011.07.1107
  • Johnson, K. M. 2013. “Making Families: Organizational Boundary Work in US Egg and Sperm Donation.” Social Science & Medicine 99: 64–71. doi: 10.1016/j.socscimed.2013.10.015
  • Keehn, J., E. Holwell, R. Abdul-Karin, L. Chin, C. Leu, M. Sauer, and R. Klitzman. 2012. “Recruiting Egg Donors Online: An Analysis of In-Vitro Fertilization Clinic and Agency Websites’ Adherence to American Society for Reproductive Medicine Guidelines.” Fertility & Sterility 98 (4): 995–1000. doi: 10.1016/j.fertnstert.2012.06.052
  • Keehn, J., E. Howell, M. Sauer, and R. Klitzman. 2015. “How Agencies Market Egg Donation on the Internet: A Qualitative Study.” Journal of Law, Medicine, and Ethics 43 (3): 610–618.
  • King, D. S. 1999. “Pre-implantation Diagnosis and the ‘New’ Eugenics.” Journal of Medical Ethics 25: 176–182. doi: 10.1136/jme.25.2.176
  • King, A. A., and M. J. Lenox. 2000. “Industry Self-regulation Without Sanctions: The Chemical Industry’s Responsible Care Program.” The Academy of Management Journal 43 (4): 698–716. doi: 10.2307/1556362
  • Levine, A. D. 2010. “Self-regulation, Compensation, and the Ethical Recruitment of Oocyte Donors.” The Hastings Center Report 40 (2): 25–36. doi: 10.1353/hcr.0.0245
  • Light, D. 2000. “The Sociological Character of Health Care Markets.” In Handbook of Social Studies in Health and Medicine, edited by Fitzpatrick Albrecht and Scrimshaw, 394–408. London: SAGE.
  • Lombard, M., J. Snyder-Duch, and C. Campanella Bracken. 2002. “Content Analysis in Mass Communication: Assessment and Reporting of Intercoder Reliability.” Human Communication Research 28 (4): 587–604. doi: 10.1111/j.1468-2958.2002.tb00826.x
  • Martin, L. J. 2009. “Reproductive Tourism in the Age of Globalization.” Globalizations 6 (2): 249–263. doi: 10.1080/14747730802500398
  • Miller, C. 2001. “Hybrid Management: Boundary Organizations, Science Policy, and Environmental Governance in the Climate Regime.” Science, Technology, and Human Values 26 (4): 478–500. doi: 10.1177/016224390102600405
  • Mitchell, R., and C. Waldby. 2010. “National Biobanks: Clinical Labor, Risk Production, and the Creation of Biovalue.” Science, Technology, and Human Values 35 (3): 330–355. doi: 10.1177/0162243909340267
  • NCSL (National Conference of State Legislatures). 2014. “State Laws Related to Insurance Coverage for Infertility Treatment.” NCSL. Accessed 15 July 2017. http://www.ncsl.org/research/health/insurance-coverage-for-infertility-laws.aspx.
  • New York State Task Force on Life and the Law, Advisory Group on Assisted Reproductive Technologies. n.d. “Thinking of Becoming an Egg Donor? Get the Facts Before You Decide!” Department of Health, State of New York.
  • Pauly, M. V. 1988. “Market Power, Monopsony, and Health Insurance Markets.” Journal of Health Economics 7: 111–128. doi: 10.1016/0167-6296(88)90011-2
  • Pennings, G. 2000. “The Right to Choose Your Donor: A Step Towards Commercialization or a Step Towards Empowering the Patient?” Human Reproduction 15 (3): 508–514. doi: 10.1093/humrep/15.3.508
  • Propp, D. A., C. Krubert, and A. Sasson. 2003. “Healthcare Economics for the Emergency Physician.” The American Journal of Emergency Medicine 21 (1): 55–60. doi: 10.1053/ajem.2003.50024
  • Reich, A. D. 2014. “Contradictions in the Commodification of Hospital Care.” American Journal of Sociology 119 (6): 1576–1628. doi: 10.1086/676836
  • Relman, A. S. 1980. “The New Medical-Industrial Complex.” The New England Journal of Medicine 303 (17): 963–970. doi: 10.1056/NEJM198010233031703
  • Romanelli, E. 1991. “The Evolution of New Organizational Forms.” Annual Review of Sociology 17: 79–103. doi: 10.1146/annurev.so.17.080191.000455
  • SART (Society for Assisted Reproductive Technology). 2007. “Egg Donor Agencies.” SART.
  • Schmidt, L. 2007. “Effects of Infertility Insurance Mandates on Fertility.” Journal of Health Economics 26 (3): 431–446. doi: 10.1016/j.jhealeco.2006.10.012
  • Silver, L. M. 1999. “How Reprogenetics Will Transform the American Family.” Hofstra Law Review 27: 649–658.
  • Spar, D. 2006. The Baby Business: How Money, Science, and Politics Drive the Commerce of Conception. Boston, MA: Harvard Business Press.
  • Steinbock, B. 2004. “Payment for Egg Donation and Surrogacy.” Mount Sinai Journal of Medicine 71 (4): 255–265.
  • Stinchcombe, A. L. 1965. “Social Structure and Organizations.” In Handbook of Organizations, edited by J. G. March, 142–193. Chicago, IL: Rand McNally.
  • The Ethics Committee of the American Society for Reproductive Medicine. 2007. “Financial Compensation of Oocyte Donors.” Fertility & Sterility 88 (2): 305–309. doi: 10.1016/j.fertnstert.2007.01.104
  • Treiser, S. n.d. “Selecting an Egg Donor: Anonymous vs. Known Parents via Egg Donation.” www.parentsviaeggdonation.org/v2/anonymous.html.
  • U.S. Census Bureau. n.d. “Documentation and Errata to Accompany the Release of July 1, 1999 Population Estimates for Incorporated Places and Minor Civil Divisions.” The U.S. Census Bureau.
  • Waldby, C. 2008. “Oocyte Markets: Women’s Reproductive Work in Embryonic Stem Cell Research.” New Genetics & Society 27 (1): 19–31. doi: 10.1080/14636770701843576
  • Yoshino, K. 2009. “Fertility Industry Oversight Is Urged.” Los Angeles Times, March 5, A8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.